Cargando…

Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis

Evidence of the immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months has been emerging. To evaluate the immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months in a systematic review and meta-analysis....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Xia, Tan, Xue, Guan, Qinghu, Zhang, Ruizhi, Lei, Shiguang, Wei, Shaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Influenza
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557567/ https://www.ncbi.nlm.nih.gov/pubmed/37794647 http://dx.doi.org/10.1080/21645515.2023.2256510

Ejemplares similares

Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial
por: Chen, Jianmin, et al.
Publicado: (2023)

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India
por: Kalappanavar, Nijalingappa K., et al.
Publicado: (2022)

Reply letter to “Immunogenicity and safety of a quadrivalent high-dose inactivated influenza vaccine compared with a standard-dose quadrivalent influenza vaccine in healthy people aged 60 years or older: a randomized Phase III trial”
por: Hadigal, Sanjay, et al.
Publicado: (2022)

Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season
por: Amicizia, Daniela, et al.
Publicado: (2023)

Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies
por: Liu, Xiaoqiang, et al.
Publicado: (2022)

Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial
por: Huang, Xiaoyuan, et al.
Publicado: (2022)

Safety and immunogenicity of a quadrivalent influenza vaccine in adults aged 60 years or above: a phase III randomized controlled clinical study
por: Fan, Renfeng, et al.
Publicado: (2021)

Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis
por: Bianculli, Pablo Manuel, et al.
Publicado: (2022)

Improved post-marketing safety surveillance of quadrivalent inactivated influenza vaccine in Mexico using a computerized, SMS-based follow-up system
por: Betancourt-Cravioto, Miguel, et al.
Publicado: (2021)

Immunogenicity and safety of two quadrivalent influenza vaccines in healthy adult and elderly participants in India - A phase III, active-controlled, randomized clinical study
por: Basu, Indraneel, et al.
Publicado: (2021)

Public health and budget impacts of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Paraguay
por: Arbo, Antonio, et al.
Publicado: (2022)

Influenza vaccine coverage in 6months-64 years-old patients affected by chronic diseases: A retrospective cohort study in Italy
por: Bianchi, Francesco Paolo, et al.
Publicado: (2023)

Cost-utility analysis of increasing uptake of universal seasonal quadrivalent influenza vaccine (QIV) in children aged 6 months and older in Germany
por: Molnar, Daniel, et al.
Publicado: (2022)

Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
por: Nurpeisova, Ainur, et al.
Publicado: (2022)

Efficient simulation of the spatial transmission dynamics of influenza
por: Tsai, Meng-Tsung, et al.
Publicado: (2010)

Gap between cognitions and behaviors among children’s guardians of influenza vaccination: The role of social influence and vaccine-related knowledge
por: Wu, Jing, et al.
Publicado: (2023)

Immunogenicity and safety of an intramuscular split-virion quadrivalent inactivated influenza vaccine in individuals aged ≥ 6 months in India
por: Agarkhedkar, Sharad, et al.
Publicado: (2019)

Tempo and Mode in the Molecular Evolution of Influenza C
por: Gatherer, Derek
Publicado: (2010)

Reply to letter to editor by Hadigal et al. regarding the immunogenicity and safety trial of high-dose influenza vaccine in adults aged ≥60 years
por: Yin, J. Kevin, et al.
Publicado: (2022)

Absolute Humidity and the Seasonal Onset of Influenza in the Continental US
por: Shaman, Jeffrey, et al.
Publicado: (2010)

Prevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USA.
por: Ross, Ted M., et al.
Publicado: (2011)

Projection of seasonal influenza severity from sequence and serological data
por: Wolf, Yuri I, et al.
Publicado: (2010)

Urbanization and humidity shape the intensity of influenza epidemics in U.S. cities
por: Dalziel, Benjamin D., et al.
Publicado: (2018)

The early diversification of influenza A/H1N1pdm
por: Nelson, Martha, et al.
Publicado: (2009)

Quantifying the transmissibility of human influenza and its seasonal variation in temperate regions
por: Truscott, James, et al.
Publicado: (2010)

Seasonal Influenza Vaccine Allocation in the Canadian Population during a Pandemic
por: Tuite, Ashleigh, et al.
Publicado: (2009)

Estimating the impact of influenza vaccination of low-risk 50–64-year-olds on acute and ICU hospital bed usage in an influenza season under endemic COVID-19 in the UK
por: Nguyen, Van Hung, et al.
Publicado: (2023)

Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: Clinical and economic impact
por: Deuffic-Burban, Sylvie, et al.
Publicado: (2009)

Prevalence and risk factors for swine influenza virus infection in the English pig population
por: Mastin, Alexander, et al.
Publicado: (2011)

Long-term influenza antibodies profiles in previously vaccinated and non-vaccinated adults
por: Sanz-Muñoz, Iván, et al.
Publicado: (2023)

Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza
por: Ross, Ted, et al.
Publicado: (2010)

The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom
por: Ghani, Azra, et al.
Publicado: (2010)

PREVALENCE OF ANTIBODIES AGAINST INFLUENZA VIRUS IN NON-VACCINATED EQUINES FROM THE BRAZILIAN PANTANAL
por: Silva, Lucas Gaíva E, et al.
Publicado: (2014)

The severity of pandemic H1N1 influenza in the United States, April – July 2009
por: Presanis, Anne M, et al.
Publicado: (2010)

Can Reactive School Closures help critical care provision during the current influenza pandemic?
por: House, Thomas, et al.
Publicado: (2009)

Recovery of H14 influenza A virus isolates from sea ducks in the Western Hemisphere
por: Nolting, Jacqueline, et al.
Publicado: (2012)

Influenza activity in Saint Joseph, Missouri 1910-1923: Evidence for an early wave of the 1918 pandemic
por: Hoffman, Brian L.
Publicado: (2011)

Fatal cases associated with pandemic influenza A (H1N1) reported in Greece.
por: Athanasiou, Maria, et al.
Publicado: (2010)

Quantifying Protection Against Influenza Virus Infection Measured by Hemagglutination-inhibition Assays in Vaccine Trials
por: Zhao, Xiahong, et al.
Publicado: (2016)

The 2009 pandemic H1N1 influenza vaccination in France: who accepted to receive the vaccine and why?
por: Raude, Jocelyn, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_en1vt5d8qdmuduncqi6fbj95vk